The chance for pharmaceutically formulating these promising aminothiadiazole inhibitors as rapid-action oral/nasal anti-COVID-19 drops/sprays should also be considered if they perfectly passed the preclinical/clinical trials with adequately significant results. 2.
← all excerpts
Strong Dual Antipolymerase/Antiexonuclease Actions of Some Aminothiadiazole Antioxidants: A Promising <i>In-Silico</i>/<i>In-Vitro</i> Repurposing Research Study against the COVID-19 Omicron Virus (B.1.1.529.3 Lineage).
1
—
—